Table 1. Correlation of DDX3 with pDvl2 and nuclear β-catenin expression and the association between pDvl2 and nuclear β-catenin in tumors from colorectal cancer patients.
Variables | Case No. | pDvl2 |
Nuclear β-catenin* |
||||
---|---|---|---|---|---|---|---|
Low (%) | High (%) | P | Low (%) | High (%) | P | ||
DDX3 | |||||||
Low | 44 | 30 (68) | 14 (32) | 0.001 | 29 (66) | 15 (34) | 0.004 |
High | 31 | 9 (29) | 22 (71) | 10 (32) | 21 (68) | ||
pDvl2 | |||||||
Low | 39 | 36 (92) | 3 (8) | < 0.001 | |||
High | 36 | 3 (8) | 33 (92) |
The number in the parentheses was the percentage of patients in the category (%).
*High-nuclear β-catenin tumors were defined as high-nuclear β-catenin/high-cytoplasmic β-catenin (N+/C+) and high-nuclear β-catenin/low-cytoplasmic β-catenin N+/C−; otherwise, low-nuclear β-catenin tumors were defined as N−/C− and N−/C+.